Sanofi

Sanofi is a pharmaceutical manufacturer headquartered in Paris, France, engaged in the research, development, manufacture, and marketing of therapeutic solutions across multiple disease areas. The company's primary product portfolio spans immunology and inflammation, rare diseases, neurology, oncology, and vaccines. Its vaccine offerings include routine pediatric immunizations (poliomyelitis, pertussis, Hib), combination vaccines covering diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B, as well as vaccines for influenza, COVID-19, meningitis, and travel-endemic diseases such as hepatitis A, typhoid, yellow fever, and rabies.

The company maintains an extensive network of research collaborations and licensing agreements to expand its pipeline. Notable partnerships include agreements with Exscientia for oncology and immunology small-molecule development, ABL Bio for alpha-synucleinopathies, and multiple collaborators in protein degradation, genome editing, and antibody-based therapies. Sanofi also co-develops treatments with partners including Teva Pharmaceuticals for inflammatory bowel disease and maintains co-promotion arrangements for select therapies.

Sanofi operates as a multinational pharmaceutical enterprise with significant scale in both manufacturing and commercialization capabilities across major global markets. The company was incorporated in France in 1994 and operates under its current name since May 2011, following a rebranding from Sanofi-Aventis. It trades on Nasdaq and maintains its primary operational base in France.